Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.035
+0.035 (3.50%)
At close: Dec 5, 2025, 4:00 PM EST
1.080
+0.045 (4.39%)
After-hours: Dec 5, 2025, 7:47 PM EST
Revelation Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6 | 4 | 3 | 4 | 66 | 93 |
| Market Cap Growth | 83.63% | 22.18% | -29.38% | -93.27% | -28.84% | - |
| Enterprise Value | -7 | -3 | -11 | -2 | 70 | - |
| Last Close Price | 1.03 | 22.13 | 721.01 | 9581.07 | 514081.81 | 506521.78 |
| PB Ratio | 0.34 | 0.82 | 0.47 | 4.24 | -666.70 | 27.32 |
| P/TBV Ratio | 0.56 | 0.82 | 0.47 | 4.24 | - | 30.99 |
| Debt / Equity Ratio | - | - | - | - | -0.17 | - |
| Quick Ratio | 6.85 | 3.40 | 2.15 | 1.18 | 0.60 | 3.72 |
| Current Ratio | 6.92 | 3.43 | 2.18 | 1.22 | 0.89 | 3.82 |
| Return on Equity (ROE) | -118.88% | -264.85% | -3.12% | -2272.77% | -723.81% | - |
| Return on Assets (ROA) | -52.64% | -52.93% | -61.08% | -179.98% | -224.21% | - |
| Return on Capital (ROIC) | -75.44% | -87.78% | -140.53% | -1400.45% | -448.74% | - |
| Return on Capital Employed (ROCE) | -75.00% | -169.40% | -130.20% | -1032.30% | 12014.20% | -111.30% |
| Earnings Yield | -229.63% | -390.38% | -3.81% | -242.55% | -18.07% | -4.07% |
| FCF Yield | -163.62% | -476.09% | -231.09% | -251.29% | -16.92% | -2.29% |
Source: S&P Capital IQ. Standard template.
Financial Sources.